The participation of CAMs in drug resistance of MM was initially reported by the resistance of MM cells against melphalan and doxorubicin treatments due to the adhesion of fibronectin (FN) to MM cells via cell adhesion molecules CD49d and CD49e [17]. The gene discussed is FN1; the disease is Miyoshi myopathy.